{"id":"W2341006816","doi":"10.1016/j.dadm.2016.03.002","title":"Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers","year":2016,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Norman Cousins Center for Psychoneuroimmunology; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; University of California, San Diego; Genentech; National Institutes of Health; Takeda Pharmaceutical Company; IXICO; H. Lundbeck A/S; Servier; Osteopathic Heritage Foundation; Eisai; Pfizer; Biogen; BioClinica; Rowan University; Parkinson Study Group; Northern California Institute for Research and Education; University of Southern California; Merck; GlaxoSmithKline; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation; GE Healthcare; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; AbbVie; Alzheimer's Association","keywords":"Autoantibody; Biomarker; Medicine; Disease; Receiver operating characteristic; Cognitive impairment; Internal medicine; Oncology; Dementia; Alzheimer's disease; Immunology; Antibody; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001185616,0.0004543142,0.0003529236,0.001126435,0.0001477986,0.0005230498,0.0002065895,0.0003818872,0.0009827919],"category_scores_gemma":[0.001789234,0.0001172111,0.0001486337,0.0004747878,0.0002272081,0.0002862487,0.0001538416,0.000308229,0.0004442935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001652324,"about_ca_system_score_gemma":0.0001989796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008195931,"about_ca_topic_score_gemma":0.0007066177,"domain_scores_codex":[0.9996464,0.0001171148,0.00003107952,0.00006566577,0.0001126576,0.00002707605],"domain_scores_gemma":[0.9993451,0.0002366315,0.0001989931,0.00002855348,0.0001103967,0.00008030605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001166839,0.0003454771,0.8338347,0.0002876785,0.000165213,0.0003414915,0.0001658329,0.0004806026,0.05799999,0.0001937877,0.001207486,0.1038108],"study_design_scores_gemma":[0.0001038158,0.001718036,0.9496613,0.0001185476,0.0001890101,0.004153315,0.0001977183,0.002862175,0.03622032,0.001026021,0.003710585,0.00003915481],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9778672,0.01127363,0.005722967,0.0003229995,0.00007704884,0.00006705538,0.0008322863,0.0002052427,0.003631616],"genre_scores_gemma":[0.9917156,0.001641203,0.005383132,0.0001629203,0.00006227304,0.00003766188,0.0003231039,0.000005048613,0.0006690135],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001185616,"threshold_uncertainty_score":0.00627017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03596480791486187,"score_gpt":0.3689495537577416,"score_spread":0.3329847458428797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}